Ulrich Meier

Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.

S. Schreiber, C. Bernstein, G. D'Haens, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Pharmacokinetics, Safety, and Efficacy of Tipranavir Boosted With Ritonavir Alone or in Combination With Other Boosted Protease Inhibitors as Part of Optimized Combination Antiretroviral Therapy in Highly Treatment-Experienced Patients (BI Study 1182.51)

C. Katlama, M. Johnson, A. Lazzarin, 2008, Journal of acquired immune deficiency syndromes.

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

J. Olesen, H. Diener, I. Husstedt, 2004, The New England journal of medicine.

Treatment response to ritonavir-boosted tipranavir versus ritonavir-boosted lopinavir in HIV-1 patients with higher lopinavir mutation scores

D. Ward, C. Boucher, S. Walmsley, 2007, AIDS.

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

J. Olesen, H. Diener, I. Husstedt, 2004, The New England journal of medicine.